Cargando…
Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study
BACKGROUND: The incidence of adenocarcinoma of esophagogastric junction (AEG) has recently risen worldwide, including in Eastern Asia. The aim of the study was to explore the short-term and long-term clinical efficacy of piggyback jejunal interposition reconstruction single-tract reconstruction (PJI...
Autores principales: | Li, Zhiguo, Dong, Jianhong, Huang, Qingxing, Zhang, Wanhong, Tao, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898954/ https://www.ncbi.nlm.nih.gov/pubmed/31810484 http://dx.doi.org/10.1186/s12957-019-1762-x |
Ejemplares similares
-
Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017) -
Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis
por: Shi, Yinan, et al.
Publicado: (2018) -
The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014) -
Total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II adenocarcinoma of the esophagogastric junction: A retrospective study
por: Wang, Liang, et al.
Publicado: (2022) -
Surgical Strategies for Siewert Type II Esophagogastric Junction Carcinomas: A Randomized Controlled Trial
por: Tao, Kai, et al.
Publicado: (2022)